| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 23.9 | 31.4 | 19.1 |
| Other income | 5.8 | -0.2 | 11.9 |
| Total income | 29.7 | 31.2 | 31.1 |
| Profit before exceptional items & tax | 1.0 | 3.1 | 11.8 |
| Profit before tax | 1.0 | 3.1 | 11.8 |
| Net profit | 1.0 | 1.4 | 11.8 |
| Operating margin | 3.4% | 9.9% | 37.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -91.50% |
|---|---|
| Net profit, quarter on quarter | -28.60% |
| Revenue, year on year | +25.10% |
| Operating profit, year on year | -4700.00% |
| Operating profit, quarter on quarter | -245.50% |
BSE results filing, NSE: ALPA. Figures extracted from the filing.
Alpa Laboratories Ltd: key numbers
- Share price
- ₹57.71
- Market cap
- ₹121.4 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹14.13 Cr
- P/E (TTM)
- 34.8×Sector 47.3×
- Promoter holding
- 57.19%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alpa Laboratories Ltd
All →Alpa Laboratories Management Change
Alpa Laboratories Ltd has appointed Ms. Diksha Jaswani as the Company Secretary and Compliance Officer (KMP), effective September 17, 2026.
Alpa Laboratories Annual Report
Alpa Laboratories Ltd. has submitted its Annual Report for FY 2025-26 and the Notice for its 38th Annual General Meeting scheduled for September 30, 2026.
Alpa Laboratories Other Announcement
Alpa Laboratories will close its transfer register from 23 to 30 Sept 2026 for the 38th AGM. This is a routine book-closure intimation under Regulation 42 with no financial impact.
Alpa Laboratories Management Change
Alpa Laboratories appointed Mrs. Radhika Biyani as an Additional Independent Director, effective 5 September 2026. Board committees were reconstituted following the change.
Alpa Laboratories Board Meeting Date
Alpa Laboratories Ltd. will hold a board meeting on August 13, 2026, to consider financial results for the quarter ended June 30, 2026, and approve the 38th AGM notice.
Alpa Laboratories Merger & Restructuring
Alpa Laboratories Ltd. has approved exploring the incorporation of an overseas entity in Nigeria, 'Alpa Biopharm Limited,' in partnership with Blueseal Pharmaceuticals Limited. This is in-principle only.